Literature DB >> 16399395

Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk.

Wolfgang W Huber1, Wolfram Parzefall.   

Abstract

Enzymes of xenobiotic metabolism are involved in the activation and detoxification of carcinogens and can play a pivotal role in the susceptibility of individuals toward chemically induced cancer. Differences in such susceptibility are often related to genetically predetermined enzyme polymorphisms but may also be caused by enzyme induction or inhibition through environmental factors or in the frame of chemopreventive intervention. In this context, coffee consumption, as an important lifestyle factor, has been under thorough investigation. Whereas the data on a potential procarcinogenic effect in some organs remained inconclusive, epidemiology has clearly revealed coffee drinkers to be at a lower risk of developing cancers of the colon and the liver and possibly of several other organs. The underlying mechanisms of such chemoprotection, modifications of xenobiotic metabolism in particular, were further investigated in rodent and in vitro models, as a result of which several individual chemoprotectants out of the >1000 constituents of coffee were identified as well as some strongly metabolized individual carcinogens against which they specifically protected. This chapter discusses the chemoprotective effects of several coffee components and whole coffee in association with modifications of the usually protective glutathione-S-transferase (GST) and the more ambivalent N-acetyltransferase (NAT). A key role is played by kahweol and cafestol (K/C), two diterpenic constituents of the unfiltered beverage that were found to reduce mutagenesis/tumorigenesis by strongly metabolized compounds, such as 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine, 7,12-dimethylbenz[a]anthracene, and aflatoxin B(1), and to cause various modifications of xenobiotic metabolism that were overwhelmingly beneficial, including induction of GST and inhibition of NAT. Other coffee components such as polyphenols and K/C-free coffee are also capable of increasing GST and partially of inhibiting NAT, although to a somewhat lesser extent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399395     DOI: 10.1016/S0076-6879(05)01020-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  10 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

Review 2.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Coffee and liver - long way to go.

Authors:  Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

4.  Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium.

Authors:  Carlotta Galeone; Alessandra Tavani; Claudio Pelucchi; Federica Turati; Deborah M Winn; Fabio Levi; Guo-Pei Yu; Hal Morgenstern; Karl Kelsey; Luigino Dal Maso; Mark P Purdue; Michael McClean; Renato Talamini; Richard B Hayes; Silvia Franceschi; Stimson Schantz; Zuo-Feng Zhang; Gilles Ferro; Shu-Chun Chuang; Paolo Boffetta; Carlo La Vecchia; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

5.  Coffee and oxidative stress: a human intervention study.

Authors:  Sergey Shaposhnikov; Thomas Hatzold; Naouale El Yamani; Philip Mark Stavro; Yolanda Lorenzo; Maria Dusinska; Astrid Reus; Wilrike Pasman; Andrew Collins
Journal:  Eur J Nutr       Date:  2016-11-17       Impact factor: 5.614

6.  Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study.

Authors:  Rashmi Sinha; Amanda J Cross; Carrie R Daniel; Barry I Graubard; Jennifer W Wu; Albert R Hollenbeck; Marc J Gunter; Yikyung Park; Neal D Freedman
Journal:  Am J Clin Nutr       Date:  2012-06-13       Impact factor: 7.045

7.  Coffee drinking and cutaneous melanoma risk in the NIH-AARP diet and health study.

Authors:  Erikka Loftfield; Neal D Freedman; Barry I Graubard; Albert R Hollenbeck; Fatma M Shebl; Susan T Mayne; Rashmi Sinha
Journal:  J Natl Cancer Inst       Date:  2015-01-20       Impact factor: 13.506

8.  Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study.

Authors:  Loredana Covolo; Donatella Placidi; Umberto Gelatti; Angela Carta; Antonio Scotto Di Carlo; Paolo Lodetti; Antonio Piccichè; Grazia Orizio; Marcello Campagna; Cecilia Arici; Stefano Porru
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

9.  Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort.

Authors:  Mia Hashibe; Carlotta Galeone; Saundra S Buys; Lisa Gren; Paolo Boffetta; Zuo-Feng Zhang; Carlo La Vecchia
Journal:  Br J Cancer       Date:  2015-08-20       Impact factor: 7.640

10.  Association of coffee consumption with risk of colorectal cancer: a meta-analysis of prospective cohort studies.

Authors:  Yong Gan; Jiang Wu; Shengchao Zhang; Liqing Li; Shiyi Cao; Naomie Mkandawire; Kun Ji; Chulani Herath; Chao Gao; Hong Xu; Yanfeng Zhou; Xingyue Song; Shanquan Chen; Yawen Chen; Tingting Yang; Jing Li; Yan Qiao; Sai Hu; Xiaoxv Yin; Zuxun Lu
Journal:  Oncotarget       Date:  2017-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.